The tetrahydroxycurcumin form has been reported to have a potent histone deacetylase (HDAC) inhibitory activity (this finding is important because epigenetic regulation or histone transformation is an essential stage in the development and growth of cancer). This evidence concerns the gene HDAC9 and cancer.